The American Civil Liberties Union (ACLU) filed a federal lawsuit Wednesday challenging a Food and Drug Administration (FDA) rule that requires women to have an in-person clinic visit in order to obtain drugs to induce an abortion.
The organization adds the rules are “especially harmful” during the coronavirus pandemic because “forcing physicians to dispense this drug in person puts patients at increased risk of COVID-19.”
In addition to claiming elective surgical abortions are “essential” for women’s health, industry giant Planned Parenthood announced during the pandemic its new tele-abortion service is now available in all 50 states.
Dr. Meera Shah, chief medical officer of Planned Parenthood Hudson Peconic, told the Associated Press (AP), “We provided a medication abortion to an EMT while she was sitting in her ambulance.
Former abortionist Dr. Anthony Levatino explained in his videos about various abortion procedures that mifepristone blocks the action of progesterone, which the mother’s body produces to nourish the pregnancy.
The FDA regulates 20,000+ drugs. But it uniquely restricts one abortion-inducing drug – and it won’t lift those restrictions in a pandemic. So the ACLU is suing. My @vicenews latest:👇 https://t.co/uhxfhPrFBM
— Carter Sherman (@carter_sherman) May 27, 2020
FDA’s medically unnecessary restrictions on mifepristone threatens to harm patients & their clinicians during a national crisis. It undermines the health care community's efforts to identify safe, effective ways to provide patients with the care they need. https://t.co/utC37UorOx pic.twitter.com/baQ1sRdkCE
— ACOG Action (@ACOGAction) May 27, 2020